Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Cash from Investing Activities (2016 - 2022)

Palisade Bio has reported Cash from Investing Activities over the past 11 years, most recently at -$10000.0 for Q4 2022.

  • Quarterly Cash from Investing Activities changed N/A to -$10000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$10000.0 through Sep 2024, up 9.09% year-over-year, with the annual reading at -$4000.0 for FY2023, 60.0% up from the prior year.
  • Cash from Investing Activities was -$10000.0 for Q4 2022 at Palisade Bio, down from -$1000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $5.0 million in Q1 2018 and troughed at -$10000.0 in Q4 2022.
  • The 3-year median for Cash from Investing Activities is -$1000.0 (2020), against an average of $997657.2.
  • The largest YoY upside for Cash from Investing Activities was 320.1% in 2018 against a maximum downside of 320.1% in 2018.
  • A 3-year view of Cash from Investing Activities shows it stood at -$1714.0 in 2018, then surged by 41.66% to -$1000.0 in 2020, then tumbled by 900.0% to -$10000.0 in 2022.
  • Per Business Quant, the three most recent readings for PALI's Cash from Investing Activities are -$10000.0 (Q4 2022), -$1000.0 (Q4 2020), and $1000.0 (Q3 2020).